Patents

US 10716835 B2: Methods and compositions for the prevention and treatment of influenza

Granted
2020-07-21
Filed
2016-09-14 application 15265620
Type
Utility · 27 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

This disclosure relates to the prevention and treatment of Influenza, and more particularly Influenza A Virus Subtype H1N1, with the use of a pharmaceutical composition comprising one or more digestive enzymes, such as pancreatic enzymes and porcine pancreatic enzymes. The disclosure further relates to the use of an individual's fecal chymotrypsin level as an indicator, e.g., biomarker of whether an individual may be more susceptible to Influenza, e.g., Influenza A Subtype H1N1, and/or whether an individual will benefit from administration of the described pharmaceutical compositions. Use of the compositions as sanitizers, antiseptics, disinfectants, and detergents, e.g., to reduce or eradicate influenza virus present on living or inanimate surfaces is also contemplated.

Source: PVGPATDIS, file of 2026-04-10 (ipg200721.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CUREMARK, LLC 55 patentsUS company or organizationRye Brook, NYCUREMARK, LLC State business registration EXACT high confidence: identical full name and state
CUREMARK LLC Form D issuer EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Joan M. FallonWhite Plains, NY61PVGPATDIS, file of 2026-04-10
Matthew HeilSherman, CT23PVGPATDIS, file of 2026-04-10
James J. FallonArmonk, NY67PVGPATDIS, file of 2026-04-10
James SzigethyMontgomery, NY8PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/54PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/16PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N7/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2016-09-16Assignment
Assignment of assignor's interest
FALLON, JAMES J. signed 2012-06-20
FALLON, JOAN M. signed 2012-06-20
HEIL, MATTHEW F. signed 2012-06-20
SZIGETHY, JAMES signed 2012-06-20
CUREMARK, LLC RYE, NY39765/254ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.